Grantham, Mayo, Van Otterloo & Co. LLC

Position in SNY — Sanofi

CIK 1352662 Boston, MA

Position in SNY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$12,165,138

+$3,055,698 QoQ

Shares Held

285,165

+50.8% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#77

of 712 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Grantham, Mayo, Van Otterloo & Co. LLC holds $3,887,775,493 across 10 Drug Manufacturers - General names. SNY ranks #8 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	7,110,133	$1,805,760,478
2	LLY	ELI LILLY & Co	743,966	$892,335,213
3	MRK	Merck & Co., Inc.	6,785,008	$871,873,528
4	GSK	GSK plc	3,599,521	$188,686,890
5	PFE	Pfizer Inc	2,179,317	$52,477,953
6	NVS	Novartis AG	245,957	$38,546,381
7	BMY	Bristol Myers Squibb Co	411,483	$23,709,650
8	SNY	Sanofi This page	285,165	$12,165,138

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,165,138	285,165	+50.8%	Shares	Sole	2026-08-13
2026-03-31	$9,109,440	189,071	+92.6%	Shares	Sole	2026-05-14
2025-12-31	$4,757,366	98,171	+15.3%	Shares	Sole	2026-02-17
2025-09-30	$4,019,740	85,164	+99.6%	Shares	Sole	2025-11-13
2025-06-30	$2,061,532	42,673	+19.2%	Shares	Sole	2025-08-13
2025-03-31	$1,985,911	35,808	+90.6%	Shares	Sole	2025-05-14
2024-12-31	$906,193	18,789	+33.3%	Shares	Sole	2025-02-13
2020-12-31	$685,119	14,100	-88.8%	Shares	Sole	2021-02-12
2020-09-30	$6,308,476	125,742	-58.3%	Shares	Sole	2020-11-13
2020-06-30	$15,383,509	301,342	-29.3%	Shares	Sole	2020-08-13
2020-03-31	$18,639,672	426,342	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.